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ABSTRACT 
Background and Objectives: Arterial stiffness is a precursor to premature cardiovascular disease. The augmentation 
index (AI) and pulse pressure (PP) are cardiovascular risk factors. The aim of this study was to define the diagnostic 
values of the AI and PP from the peripheral arterial and central aortic waveforms in healthy subjects. Subjects 
and Methods: We recruited 522 consecutive subjects (mean age 46.3±9.6 years, 290 males) who came to our 
facility for a comprehensive medical testing. We measured the body mass index (BMI), blood pressure, peripheral 
and central PP, and a pulse wave analysis that included the central and peripheral AI. Results: The peripheral 
and central AIs in the female subjects were significantly higher than that in the male subjects (p<0.001). The 
peripheral and central PPs in the subjects with hyperlipidemia were significantly higher than subjects with 
normal lipid profiles (p<0.001). The peripheral and central PPs and peripheral and central AIs significantly in-
creased with age. Conclusion: Pending validation in prospective outcome-based studies, a peripheral PP of 70 
mmHg, central PP of 50 mmHg, peripheral AI of 100%, and central AI of 40% may be preliminary values in adult 
subjects. (Korean Circ J 2010;40:165-171) 
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Introduction 
 
Arterial stiffness is associated with cardiovascular risk 
factors, as well as cardiovascular morbidity and morta-
lity in older subjects and in patients suffering from 
hypertension, diabetes, end-stage renal disease, and sys-
tolic dysfunction.
1-6) The aortic augmentation index (AI) 
may be a surrogate measure of arterial stiffness.
7)8) Bra-
chial pulse pressure (PP) is also an independent predic-
tor of the risk of cardiovascular disease in the general 
population.
9-12) 
Although the clinical importance of the brachial PP 
is clear, central PP may correlate more closely with the 
risk of cardiovascular disease than the brachial pres-
sure.
13) Deriving the central pressure from the radial pres-
sure waveforms gives similar results as directly measur-
ing the central pressure.
14) This important risk factor 
remains underused in routine clinical practice for risk 
prediction, partly because operational thresholds for 
diagnosing abnormal elevations in arterial stiffness have 
not been defined. The reference values for the AI and 
PP in apparently healthy subjects are currently unknown. 
Thus, the aim of this study was to define the diagnos-
tic values of the AI and PP obtained from the periph-
eral arterial and central aortic waveforms in healthy 
subjects. 
 
Subjects and Methods  
 
Subjects 
We recruited 522 consecutive subjects (mean age 46.3 
±9.6 years, 290 males) who were seen at our facility for 
comprehensive medical testing from April, 2006, to May, 
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2006. We measured the body mass index (BMI), serum 
cholesterol level, systolic (SBP) and diastolic blood pres-
sures (DBP), central and peripheral PP, and performed 
a pulse wave analysis that included the central and pe-
ripheral AIs. 
The BMI was calculated as the body weight (kg) to 
height (m) squared. Hyperlipidemia was defined as a 
total cholesterol level exceeding 200 mg/dL. The bra-
chial blood pressure was read from the dominant arm 
in supine subjects. SBP and DBP readings were taken 
with the dominant arm supported while the subjects 
were seated after at least 10 minutes of quiet rest, with 
a mercury column sphygmomanometer and cuff-size 
adjustment based on the arm circumference. The base-
line values for both the SBP and DBP were averaged 
from two separate measurements taken by the exami-
ner. The subjects with a history of hypertension or dia-
betes, any previous or concomitant cardiovascular dise-
ase, or cardiac arrhythmias were excluded from the study. 
All patients gave their informed consent before enroll-
ment into the study. The interobserver variability was 
88% and the intra-observer variability was 92%. 
 
Measurement of the pulse pressure and augmen-
tation index 
The peripheral and central PPs were defined as the 
difference between the SBP and DBP derived from the 
brachial blood pressure and aortic pulse wave, respec-
tively. The AI was calculated from the left radial artery 
pulse waves. The data were collected directly into a por-
table computer; integral software was used to generate 
an averaged waveform (Gaon 21A System, Hanbyul, Jeon-
ju, Korea). The systolic part of the peripheral arterial 
waveform was characterized by two pressure peaks. The 
first peak was caused by the left ventricular ejection, wh-
ereas the second peak was a result of the wave reflection. 
The difference between both pressure peaks reflected the 
degree to which the peripheral arterial pressure was aug-
mented by the wave reflection.
15-17) The peripheral AI was 
defined as the ratio of the second to first peak of the pres-
sure wave expressed as a percentage. The central AI was 
calculated from the peripheral AI by an automatic ma-
thematical transformation. The differences in the con-
secutive mean data during the repeated measurements 
were less than 0.5 m/s, and the mean data was used for 
the final analysis. 
 
Statistical analysis 
Statistical analyses were performed using Statistical 
Package for the Social Sciences 12.0 for Windows soft-
ware. Chi-square tests and unpaired t-tests were used 
for statistical differences of the categorical and conti-
nuous parameters between genders, respectively. The 
correlations between the age and other parameters were 
determined by a linear regression analysis. The statisti-
cal differences among each age group for the contin-
uous variables were evaluated using a one-way analysis 
of variance. We rounded out the 95th prediction bands 
in order to determine the diagnostic thresholds for the 
peripheral PP, peripheral AI, central PP, and central AI 
according to age (Fig. 1). The data are expressed as the 
mean±standard deviation. A p of less than 0.05 was 
Peripheral AI  Central AI 
Fig. 1. Statistical analysis of the pulse pressure (PP) and augmentation index (AI).
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considered statistically significant. 
 
Results 
 
Baseline clinical characteristics   
The sample was comprised of 290 males and 232 fe-
males. The mean age of the participants was similar for 
both the males and females. The BMI, stature and body 
weight, and incidence of being a smoker, and having hy-
perlipidemia was higher in males than females (Table 1). 
 
Relationship of the pulse pressure and augmen-
tation index according to the gender 
The peripheral PP in the males was significantly higher 
than that in females (p=0.006). There was no signifi-
cant difference in the central PP between the two groups. 
The peripheral and central AIs in the females were sig-
nificantly higher than in males (p<0.001) (Fig. 2).  
Relationship of the pulse pressure and augment-
ation index according to hyperlipidemia   
The peripheral PP (p<0.005) and peripheral AI (p< 
0.033) in the subjects with hyperlipidemia were signi-
ficantly higher than in subjects with normal lipid pro-
files. Central PP and AI levels were similar in the two 
groups (Fig. 3). 
 
Relationship of the pulse pressure and augment-
ation index according to the age   
The peripheral and central PPs and peripheral and 
central AIs had a significant positive correlation to age 
(Figs. 4 and 5). When divided into groups by age, the 
peripheral and central PPs and AIs significantly increas-
ed with age (Fig. 6) (Table 2). 
To determine the diagnostic values, we rounded out 
the upper limit of the 95th prediction bands for middle-
aged men (40 years). The procedure yielded the follow-
Table 1. Baseline clinical characteristics of study group
  Total  Male  Female  p 
No. of patients (%) 
Age (year)   
Height (cm) 
Weight (kg) 
BMI (kg/m
2) 
Resting HR (bpm) 
Smoking (%) 
Hyperlipidemia (%) 
Serum creatinine (mg/dL) 
522 
46.3±9.6 
164.0±8.7 
063.3±10.6 
23.5±2.9 
67.3±9.6 
145 (27.8) 
213 (40.8) 
1.07±0.56 
290 (55.6) 
45.7±8.7 
169.7±6.0 
68.7±9.5 
23.9±2.9 
67.7±9.7 
137 (47.2) 
124 (42.8) 
1.04±0.18 
232 (44.4) 
47.1±10.6 
156.9±5.8 
056.6±7.5 
23.0±2.7 
66.8±9.5 
8 (3.4) 
89 (38.4) 
1.10±0.82 
 
<0.131
<0.001
<0.001
<0.001
<0.308
<0.001
<0.310
<0.276
BMI: body mass index, HR: heart rate 
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Fig. 2. Relationship of the pulse pressure (PP) and augmentation index (AI) to gender. 
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ing thresholds: 70 mmHg for the peripheral PP, 50 mmHg 
for the central PP, 100% for the peripheral AI, and 40% 
for the central AI. The aforementioned values for the 
peripheral and central PPs and peripheral and central 
AIs needed to be adjusted for age according to the cur-
vilinear relationships. Those values increase approxima-
Fig. 3. Relationship of the pulse pressure (PP) and augmentation index (AI) to hyperlipidemia. 
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Fig. 4. Relationship of the pulse pressure to age.
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tely 3.3 mmHg for peripheral PP, 5.0 mmHg for cen-
tral PP, 6.6% for peripheral AI, and 4.0% for central 
AI for each decade of age over 40 years (Table 3). 
 
Discussion 
 
The main finding in this study was that the PP and 
AI significantly increased with gender, hyperlipidemia, 
and age. Further, these are the data in Koreans on diag-
nostic values for the PP and AI. 
Gatzka et al.
18) found that women had smaller and 
stiffer elastic arteries than men, and that the ventricu-
lar contraction and outflow were slower in women than 
in men: it takes longer to reach the systolic peak in wo-
men and the overall systole is prolonged, which is caus-
ed by their shorter statue. This change in the wave re-
flection properties causes a higher AI in women than 
men. Further, these changes in the elastic artery stiff-
ness parallel the peripheral and central PPs.
19)20) We 
also found that gender was significantly related to the 
AI. However, we did not adjust PP levels for smoking, 
BMI, or hyperlipidemia.   
Table 2. Distribution of parameters according to decade of age
  ≤39 years  40-49 years  50-59 years  ≥60 years  p 
No. of patients 
Male (%) 
BMI (kg/m
2) 
Current smoker (%) 
Hyperlipidemia 
Resting heart rate (bpm) 
Peripheral SBP (mmHg) 
Peripheral DBP (mmHg) 
Peripheral PP (mmHg) 
Peripheral AI (%) 
Central SBP (mmHg) 
Central DBP (mmHg) 
Central PP (mmHg) 
Central AI (%) 
134 
74 (55.2) 
22.9±3.4 
38 (28.4) 
50 (37.3) 
69.7±10.8 
120.3±15.1 
70.0±8.8 
50.4±11.3 
81.2±12.9 
107.0±12.5 
70.0±8.8 
37.0±8.6 
23.4±8.4 
226 
132 (58.4) 
23.5±2.6 
067 (29.6) 
093(41.2) 
66.4±9.0 
119.1±14.6 
72.1±10.2 
47.0±10.4 
89.2±15.7 
109.3±12.6 
72.0±10.2 
37.2±8.1 
28.9±10.3 
108 
65 (60.2) 
24.4±2.6 
29 (26.9) 
45 (41.7) 
66.0±9.0 
127.4±15.5 
76.8±11.0 
50.6±10.2 
91.7±10.8 
117.7±13.8 
76.8±11.0 
40.9±9.0 
29.7±9.1 
54 
19 (35.2) 
23.5±2.7 
11 (20.4) 
25 (46.3) 
68.1±9.8 
128.8±19.5 
74.0±12.7 
54.8±15.2 
94.9±12.1 
118.8±17.9 
74.0±12.7 
44.9±12.8 
34.1±9.0 
 
<0.013
<0.001
<0.585
<0.707
<0.005
<0.001
<0.001
<0.001
<0.001
<0.001
<0.001
<0.001
<0.001
BMI: body mass index, SBP: systolic blood pressure, DBP: diastolic blood pressure, PP: pulse pressure, AI: augmentation index 
 
Fig. 6. Relationship of the pulse pressure (PP) and augmentation index (AI) according to the decade of age. 
P
e
r
i
p
h
e
r
a
l
 
P
P
 
(
m
m
H
g
)
 
80
70
60
50
40
30
≤3 9           4 0 -4 9           5 0 -5 9          ≥60
C
e
n
t
r
a
l
 
P
P
 
(
m
m
H
g
)
 
70
60
50
40
30
P
e
r
i
p
h
e
r
a
l
 
A
I
 
(
%
)
 
120
100
80
60
C
e
n
t
r
a
l
 
A
I
 
(
%
)
 
60
50
40
30
20
10
   
p=0.016 
p=0.008 
 
p=0.002 
p=0.001
p=0.001 
p<0.001 
 
 
p=0.002
p=0.004 
p=0.001 
     
p<0.001
p=0.021 
p=0.001 
p=0.001
p<0.001 
Years 
≤3 9            4 0 -4 9           5 0 -5 9          ≥60 
Years 
≤3 9           4 0 -4 9           5 0 -5 9          ≥60
Years Years 
≤3 9            4 0 -4 9           5 0 -5 9          ≥60  
 
170·Augmentation Index and Pulse Pressure in Healthy Korean Subjects 
 
Hyperlipidemia is a primary risk factor for the deve-
lopment of coronary atherosclerosis. Wilkinson et al.
8)21) 
investigated the relation between serum cholesterol, ar-
terial stiffness, and central arterial blood pressure. Peri-
pheral blood pressure was similar, but the central PP 
and AI were higher in the group with hyperlipidemia. 
However, endothelial dysfunction and reduced nitric 
oxide bioavailability are associated with hyperlipidemia, 
which may contribute to the increase in the arterial stiff-
ness and AI. We also found that hyperlipidemia was sig-
nificantly related to the PP and AI. 
With increased age, the walls of the systemic arteries 
undergo certain histologic changes. Those changes oc-
cur independently of any alterations attributed to ath-
erosclerosis. The principal changes with age occur as 
the intima undergoes hyperplasia. In the load-bearing 
media, the elastic fibers and laminae lose the orderly ar-
rangement seen in early life and display thinning, split-
ting, fraying, and fragmentation. The age related thin-
ning and fragmentation of elastin and the increase in col-
lagen are not seen in muscular arteries. Those func-
tional and structural changes in the elastic arteries and 
arterioles cause an increase in both stiffness and resist-
ance.
22-24) Our data were in good agreement with the 
previous studies, regarding the findings that the peri-
pheral and central PPs and peripheral and central AIs 
had a significant positive correlation to age. 
Recently, many studies have examined the diagnos-
tic values of the AI and PP in different races. Asmar et 
al.
25) studied 61,724 consecutive subjects, and found that 
the mean value of the peripheral PP across all age ranges 
was close to 50 mmHg, and thus suggested 65 mmHg as 
a diagnostic value. Mitchell et al.
26) who studied the Fra-
mingham Heart Study Offspring Cohort, suggested that 
the carotid AIs were 33% and 37% in men and women, 
respectively. In the European study, which included 534 
Europeans, the proposed values for the arterial measure-
ments according to age, were approximately 60 mmHg 
for the peripheral PP, 40 mmHg for the central PP, 90% 
for the peripheral AI, and 30% for the central AI.
27) In an-
other study which included 185 South Africans of black 
ancestry, the value at an age of 30 years old was 70 mmHg 
for the peripheral PP, 50 mmHg for the central PP, 100% 
for the peripheral AI, and 40% for the central AI. Those 
values needed to be adjusted by 2.5 mmHg, 4.0 mmHg, 
10%, and 6%, respectively, for each decade of age over 30 
years.
28) In a Chinese study, the approximate values for 
normal peripheral and central PP values were 58 mmHg 
and 48 mmHg, respectively, and those for the peripheral 
and central AIs were 105% and 45%, respectively.
29) The 
proposed values in the South African and Chinese were 
higher than those estimates in the Europeans, but were 
similar to our Korean data. This discrepancy might be 
explained by the Korean participants being older than 
the Europeans, but shorter height in Koreans subjects is 
probably the main determinant of these ethnic differences. 
There were several limitations to this study. First, we 
analyzed a small number of patients over 60 years old, 
limiting our ability to detect significant differences in 
that age group. Studies involving a large number of pa-
tients are essential to generalize the results of this study. 
Second, the AI could have been influenced by the heart 
rate. Therefore, although we did not adjust for the heart 
rate, we measured it after 10 minutes of a quiet rest. Th-
ird, our data was from a single center; large-scale, long-
term follow-up studies will be required in the future. 
Fourth, this study did not exclude smoking and hyper-
lipidemia, and may be difficult to apply to general po-
pulations. 
In conclusion, pending further validation in prospec-
tive outcome-based studies, a peripheral PP of 70 mmHg, 
central PP of 50 mmHg, peripheral AI of 100%, and 
central AI of 40% may be preliminary diagnostic values 
in adult subjects.   
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Table 3. Reference value of the PP and AI by decade of age
  ≤39 years  40-49 years  50-59 years  ≥60 years  All
No. of patients 
Peripheral PP (mmHg) 
Mean 
95th 
Peripheral AI (%) 
Mean 
95th  
Central PP (mmHg) 
Mean 
95th  
Central AI (%) 
Mean 
95th 
134 
 
50.4 
69.5 
 
81.2 
99.3 
 
37.2 
51.3 
 
23.4 
37.0 
226 
 
047.0 
063.7 
 
089.2 
111.7 
 
037.2 
050.0 
 
028.9 
046.7 
108 
 
050.6 
070.6 
 
091.7 
107.6 
 
040.9 
057.2 
 
029.7 
043.0 
54 
 
054.8 
079.3 
 
094.7 
118.3 
 
044.9 
064.5 
 
034.1 
052.3 
522
 
049.4
070.0
 
088.3
108.9
 
038.7
055.0
 
028.2
043.0
PP: pulse pressure, AI: augmentation index 
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